相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study
Eun Sil Koh et al.
SCIENTIFIC REPORTS (2021)
Angiopoietin-2 is associated with metabolic syndrome in chronic kidney disease
Fan-Chi Chang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
Tao Hong et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2021)
Increased serum asprosin is correlated with diabetic nephropathy
Rui Wang et al.
DIABETOLOGY & METABOLIC SYNDROME (2021)
Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy
Golnoosh Goodarzi et al.
MOLECULAR BIOLOGY REPORTS (2021)
Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
Xinyue Zhang et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Energy Regulation Mechanism and Therapeutic Potential of Asprosin
Jennifer G. Hoffmann et al.
DIABETES (2020)
Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease
Hongyu Zhang et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Asprosin: A Novel Player in Metabolic Diseases
Mingyang Yuan et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
The prevalence and associated factors of metabolic syndrome among patients with end-stage renal failure undergoing hemodialysis in Indonesia
Maimun Syukri et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
Lei Zhang et al.
CLINICA CHIMICA ACTA (2019)
Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
Kader Ugur et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2019)
Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle
Tae Woo Jung et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
Taeseung Lee et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Prevalence of metabolic syndrome in dialysis and transplant patients
Sameeha AlShelleh et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
Erwei Li et al.
CELL METABOLISM (2019)
Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity
Min Wang et al.
ANNALS OF NUTRITION AND METABOLISM (2019)
Associations of Cardiovascular and All-Cause Mortality with Metabolic Syndrome in Hemodialysis Patients: A Prospective Single-Center Study
Zorica Dimitrijevic et al.
MEDICINA-LITHUANIA (2019)
Serum asprosin levels and bariatric surgery outcomes in obese adults
Chao-Yung Wang et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: Asprosin
Ahmet Cagdas Acara et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2018)
Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
Yuren Wang et al.
MEDIATORS OF INFLAMMATION (2018)
Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
Xing Li et al.
MEDIATORS OF INFLAMMATION (2018)
Asprosin is a centrally acting orexigenic hormone
Clemens Duerrschmid et al.
NATURE MEDICINE (2017)
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Chase Romere et al.
CELL (2016)
Metabolic syndrome pandemic
Scott M. Grundy
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Prevalence of the metabolic syndrome in hemodialysis
G. Tsangalis et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2007)
Metabolic syndrome predicts hospitalization in hemodialysis patients: A prospective Asian cohort study
Shao-Yu Yang et al.
BLOOD PURIFICATION (2007)
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
KGMM Alberti et al.
DIABETIC MEDICINE (2006)
分享论文
